Electrochemistry for vaccine synthesis and tumor destruction

Inventor: Michael Pravica 

Dr. Michael Pravica is a professor of physics and a member of HiPSEC (High Pressure and Engineering Center). His expertise includes Explosives, High Pressure Science, Raman, Infrared, Nuclear Magnetic Resonance and X-ray Spectroscopies, Accelerator Physics 

Invention:

Propose using electrochemistry to selectively damage the interior of viruses and cancerous cells by flowing a current (aqueously in in vivo) through viruses tumors (respectively). The essence of the idea is that the interior of viruses and cells tends to be more conductive (e.g. RNA and DNA are acids) than the exterior coat/capsid or cell wall. 

Benefits:

• Not altering fundamental biochemistry of the cells (e.g. by using m-RNA vaccines) - just damaging a solution of viruses or a tumor using an electric current
• An easy method to create vaccines and to destroy tumors. 
• The process can be easily upscaled. 
• Electrochemistry is a straightforward means to synthesize inorganic materials (e.g. via metallic deposition) and breakdown of simple molecules such as water into hydrogen and oxygen, however, it has not been used to modify large molecules such as DNA or RNA. 

Market opportunity: 

Based on reports by the IBISWorld, the scientific Research & Development in the US has a current revenue of $264.2B and has a CAGR of 2.3% between 2023 and 2028. Furthermore, the biological and biochemical product manufacturing is stated to have reached $98.8B in revenue and expected 7.3% CAGR.

Intellectual property:

• Early Stage